These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3012642)

  • 1. Environmental chemicals in hepatocarcinogenesis: the mechanism of tumor promoters.
    Schwarz LR; Greim H
    Prog Liver Dis; 1986; 8():581-95. PubMed ID: 3012642
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of cell-cell communication by tumor promoters.
    Trosko JE; Yotti LP; Warren ST; Tsushimoto G; Chang C
    Carcinog Compr Surv; 1982; 7():565-85. PubMed ID: 7039834
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth regulation by peroxisome proliferators: opposing activities in early and late G1.
    Ledwith BJ; Johnson TE; Wagner LK; Pauley CJ; Manam S; Galloway SM; Nichols WW
    Cancer Res; 1996 Jul; 56(14):3257-64. PubMed ID: 8764118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver tumour promotion by phenobarbital: comparison of rat and human studies.
    McLean AE; Driver HE; Sutherland IA
    Prog Clin Biol Res; 1992; 374():251-9. PubMed ID: 1320274
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver cell cancer: insights into the pathogenesis of hepatocellular carcinoma in humans from experimental hepatocarcinogenesis in the rat.
    Farber E
    Monogr Pathol; 1987; (28):199-222. PubMed ID: 3023976
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis.
    Popp JA; Cattley RC; Miller RT; Marsman DS
    Prog Clin Biol Res; 1994; 387():193-207. PubMed ID: 7972246
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of trypan blue on hepatocarcinogenesis in rats given ethionine or N-2-fluorenylacetamide.
    Ito N; Farber E
    J Natl Cancer Inst; 1966 Dec; 37(6):775-85. PubMed ID: 4289069
    [No Abstract]   [Full Text] [Related]  

  • 8. Promotion of hepatocarcinogenesis in humans and animal models.
    Köhle C; Schwarz M; Bock KW
    Arch Toxicol; 2008 Sep; 82(9):623-31. PubMed ID: 18204979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic effects of liver tumor promoters and implications for health effects.
    Williams GM
    Environ Health Perspect; 1983 Apr; 50():177-83. PubMed ID: 6873012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of epidermal growth factor and insulin and the autophosphorylation of their receptors in experimental primary hepatocellular carcinomas.
    Lev-Ran A; Carr BI; Hwang DL; Roitman A
    Cancer Res; 1986 Sep; 46(9):4656-9. PubMed ID: 3015391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aflatoxin carcinogenesis: interspecies potency differences and relevance for human risk assessment.
    Wogan GN
    Prog Clin Biol Res; 1992; 374():123-37. PubMed ID: 1320271
    [No Abstract]   [Full Text] [Related]  

  • 12. The cellular analysis of liver carcinogenesis. V. Ultrastructural alterations within hepatocellular carcinoma induced by ethionine.
    Merkow LP; Epstein SM; Slifkin M; Farber E; Pardo M
    Lab Invest; 1972 Mar; 26(3):300-5. PubMed ID: 4335732
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathobiology of chemical hepatocarcinogenesis: recent progress and perspectives. Part II. Metabolic and molecular changes.
    Bannasch P
    J Gastroenterol Hepatol; 1990; 5(3):310-20. PubMed ID: 1966482
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathobiology of chemical hepatocarcinogenesis: recent progress and perspectives. Part I. Cytomorphological changes and cell proliferation.
    Bannasch P
    J Gastroenterol Hepatol; 1990; 5(2):149-59. PubMed ID: 1966478
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatocellular carcinoma cell lines from diethylnitrosamine phenobarbital-treated rats. Characterization and sensitivity to endothall, a protein serine/threonine phosphatase-2A inhibitor.
    Thièry JP; Blazsek I; Legras S; Marion S; Reynes M; Anjo A; Adam R; Misset JL
    Hepatology; 1999 May; 29(5):1406-17. PubMed ID: 10216123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proliferation of peroxisomes and the hepatocarcinogenic process].
    Palut D
    Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocarcinogenesis of peroxisome proliferators.
    Rao MS; Reddy JK
    Ann N Y Acad Sci; 1996 Dec; 804():573-87. PubMed ID: 8993574
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
    Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive RNA-DNA hybridization of nuclear and microsomal RNA during diethylnitrosamine hepatocarcinogenesis.
    Garrett CT; Katz C; Moore RE; Pitot HC
    Cancer Res; 1973 Jul; 33(7):1662-9. PubMed ID: 4352795
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatocarcinogenesis: a dynamic cellular perspective.
    Farber E; Sarma DS
    Lab Invest; 1987 Jan; 56(1):4-22. PubMed ID: 3025514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.